Stock 2696 SHANGHAI HENLIUS BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:35 2024-05-22 am EDT 		5-day change 1st Jan Change
18.84 HKD +4.67% Intraday chart for Shanghai Henlius Biotech, Inc. -.--% +35.54%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Henlius' EU Marketing Application for Denosumab Biosimilar Accepted and Validated by Regulator MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. 2696 Stock
  4. Revisions Shanghai Henlius Biotech, Inc.